Laura is a Director of Fipra International and has more than 20 years experience as a  public affairs professional, with a particular focus in the Life Sciences sector.

Laura advises both companies and associations on EU legislation, policy and antitrust matters. She has long experience of developing strategies of engagement at the national and European level to deliver desired political outcomes. Laura has been instrumental in assisting stakeholder coalitions on policies relating to patient access to healthcare, financing models for innovative medicines and healthcare reform. From 2001 to 2002, Laura worked in Washington DC, advising on transatlantic antitrust issues and during this time established the Fipra network in the USA. Laura has been Vice-Chair of Business for New Europe (BNE), a coalition of business leaders advocating for positive engagement in the EU. Laura graduated in Modern Languages from Oxford in 1994.